The Effect of Different Deproteinising Agents on the Clinical Success of Fissure Sealants in Permanent Teeth
Condition(s) studied
Investigational drug(s) / intervention(s)
application of deproteinization agents: Since there is no in vivo study in the literature evaluating the clinical success of the use of hypochlorous acid for deproteinization in fissure sealants, our planned study is the first in this regard.
Study summary
Investigation of the effect of deproteinization agents on the clinical success of non-invasive fissure sealant application, which is a non-invasive method used to prevent caries formation or to stop the progression of initial caries lesions limited to enamel on tooth surfaces thought to be at high risk of caries.
Eligibility
Primary outcome measure(s)
- Modified Simonsen Criteria — Following the sealant application, controls will be made at 6, 12, 24 and 36 months.
Modified Simonsen Criteria Score 0 Fissure sealant is completely in the mouth and there is no new caries. Score 1 Partial loss of fissure sealant, no new caries. Score 2 Partial loss of fissure sealant and new caries. Score 3 Complete loss of fissure sealant, no new caries. Score 4 Complete loss of fissure sealant and new caries.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tokat Gaziosmanpaşa University | Tokat Province | Turkey (Türkiye) | Recruiting |
More Tokat Gaziosmanpasa University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06988098 on ClinicalTrials.gov ↗ ← All trials in Turkey